Patent · US Active

Antibody variants

US8440190B2 · kind B2 · utility

3Cited by
3References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 14, 2005
Grant dateMay 14, 2013
Priority date
Expiry dateAug 17, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to an antibody which is modified version of a therapeutic antibody with affinity for a cell-surface antigen, the antibody having reduced affinity for the antigen compared with the therapeutic antibody as a result of a modification or modifications to the antibody molecule, wherein the antibody is capable of inducing immunological tolerance to the therapeutic antibody. The invention further relates to a method of inducing immunological tolerance to a therapeutic antibody, comprising administering to a patient an antibody which is a modified version of the therapeutic antibody and which has reduced affinity for the antigen as compared with the therapeutic antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.